Emma A. Meagher, MD
Professor of Medicine (Translational Medicine and Human Genetics) at the Hospital of the University of Pennsylvania
Director, Master of Science in Translational Research degree program , University of Pennsylvania, Perelman School of Medicine
Director, Translational Research Education, Institute of Translational Medicine and Therapeutics, University of Pennsylvania, Perelman School of Medicine
Chief Clinical Research Officer, University of Pennsylvania, Perelman School of Medicine
Director, Master of Regulatory Affairs degree program, University of Pennsylvania, Perelman School of Medicine
Director, Master of Science in Regulatory Science degree program, University of Pennsylvania, Perelman School of Medicine
Senior Associate Vice Provost for Human Research, University of Pennsylvania
Associate Dean of Master’s Programs, University of Pennsylvania, Perelman School of Medicine
Member, Internal Advisory Board, Penn Colton Center for Autoimmunity
Vice President for Clinical Research, University of Pennsylvania Health System
Senior Vice Dean for Clinical and Translational Research, University of Pennsylvania, Perelman School of Medicine
Department: Medicine
Contact information
Office of the Dean, PSOM
University of Pennsylvania
8032 Maloney Building
3400 Spruce Street
Philadelphia, PA 19104-4283
University of Pennsylvania
8032 Maloney Building
3400 Spruce Street
Philadelphia, PA 19104-4283
Office: 215-662-2174
Fax: 215-662-7141
Fax: 215-662-7141
Email:
EMMA@UPENN.EDU
EMMA@UPENN.EDU
Education:
M.D. (Medicine)
Royal College of Surgeons in Ireland, 1987.
M.D. (Medicine)
Royal College of Surgeons in Ireland, 1987.
Links
2014 Alpha Omega Alpha Robert J. Glaser Distinguished Teacher Award
Associate Dean, PSOM Master's and Certificate Programs
Faculty, Department of Systems Pharmacology and Translational Therapeutics
Director, ITMAT Education
Office of Inclusion, Diversity, and Equity; Action for Cultural Transformation (ACT) Strategic Pillar Co-Leader
LinkedIn Profile
Co-PI, Clinical & Translational Science Award (CTSA)
Member, Human Research Advisory Committee
Internal Advisory Board, Penn Colton Center for Autoimmunity
Director, Combined Degree Programs: MD/Master of Science in Translational Research (MSTR)
Professor of Medicine, Perelman School of Medicine
Member, University Research Compliance Committee
Penn Medicine Faculty Biosketch
Director, Office of Clinical Research
Office of the Dean, Leadership
Faculty, Perelman School of Medicine
Co-PI, Clinical & Translational Science Award (CTSA)
Coursera Instructor
Permanent link2014 Alpha Omega Alpha Robert J. Glaser Distinguished Teacher Award
Associate Dean, PSOM Master's and Certificate Programs
Faculty, Department of Systems Pharmacology and Translational Therapeutics
Director, ITMAT Education
Office of Inclusion, Diversity, and Equity; Action for Cultural Transformation (ACT) Strategic Pillar Co-Leader
LinkedIn Profile
Co-PI, Clinical & Translational Science Award (CTSA)
Member, Human Research Advisory Committee
Internal Advisory Board, Penn Colton Center for Autoimmunity
Director, Combined Degree Programs: MD/Master of Science in Translational Research (MSTR)
Professor of Medicine, Perelman School of Medicine
Member, University Research Compliance Committee
Penn Medicine Faculty Biosketch
Director, Office of Clinical Research
Office of the Dean, Leadership
Faculty, Perelman School of Medicine
Co-PI, Clinical & Translational Science Award (CTSA)
Coursera Instructor
Description of Research Expertise
Dr. Meagher’s research expertise lies in the development of novel therapeutics for dyslipidemia and the evaluation of educational methods for training clinical and translational scientists.Description of Clinical Expertise
Cardiovascular risk reduction, with a focus on women’s cardiovascular health, hypertension, and dyslipidemia.Selected Publications
Valenta AL, Meagher EA, Tachinardi U, Starren J.: Core Informatics Competencies for Clinical and Translational Scientists: What Do Our Customers and Collaborators Need to Know? Journal of the American Medical Informatics Association(23), 835-839, April 2016.Gabriel SE, Jackson R, Meagher E, Meyer RJ, Patterson A, Pinner RW, Reiss TF, Rosenblatt M, Tosi LL and Steele SJ (Chair).: Centers of Excellence in Regulatory Science and Innovation (CERSI) -- Program Evaluation. A Report to the FDA Science Board from the CERSI Program Evaluation Subcommittee February 2016.
Marantz PR, Selker HP, Meagher EA.: Certification of Clinical and Translational Researchers: An Ill-Conceived Notion. Journal of Clinical and Translational Science 1(1): 3-4, February 2017.
Rubio DM, Robinson GFWB, Gabrilove J, Meagher EA.: Creating Effective Career Development Programs. Journal of Clinical and Translational Science 1(2): 83-87, April 2017.
Blom D, Averna M, Meagher EA, du Toit Theron, H, Sirtori C, Hegele R, Shah P, Gaudet D, Stefanutti C, Vigna G, Foulds P, Bloedon L, Rader D, Cuchel M: Long-Term Efficacy and Safety of Lomitapide for the Treatment of Homozygous Familial Hypercholesterolemia: Results of the Phase 3 Extension Trial. Circulation 132(Issue Suppl 3), Nov 2015 Notes: Poster Presentation.
Adamo JE, Wilhelm EE, Steele SJ.: Advancing a Vision for Regulatory Science Training. Clinical Translational Sciences 8(5): 615-618, Oct 2015.
Pfund C, Spencer KC, Asquith P, House SC, Miller S, Sorkness CA: Building National Capacity for Research Mentor Training: An Evidence-Based Approach to Training the Trainers. CBE Life Sciences Education 14:ar24(2): 1-12, June 2015.
Stefanutti C, Blom DJ, Averna MR, Meagher EA, Theron Hd, Marais AD, Hegele RA, Sirtori CR, Shah PK, Gaudet D, Vigna GB, Sachais BS, Di Giacomo S, du Plessis AM, Bloedon LT, Balser J, Rader DJ, Cuchel M.: The lipid-lowering effects of lomitapide are unaffected by adjunctive apheresis in patients with homozygous familial hypercholesterolaemia - a post-hoc analysis of a Phase 3, single-arm, open-label trial. Atherosclerosis 240(2): 408-414, June 2015.
Raper A, Kolansky DM, Sachais BS, Meagher EA, Baer AL, Cuchel M.: Long-term clinical results of microsomal triglyceride transfer protein inhibitor use in a patient with homozygous familial hypercholesterolemia. Journal of Clinical Lipidology 9(1): 107-112, Jan-Feb 2015.
Stefanutti C, Blom D, Averna M, Meagher E, du Toit Theron, H, Marais D, Hegele R, Sirtori C, Shah P, Gaudet D, Vigna G, du Plessis A, Bloedon L, Rader D, Cuchel M: Homozygous Familial Hypercholesterolemia Presents with a Wide Spectrum of LDL-C Levels in a Genetically Confirmed Cohort of Patients. The Second World Congress of Clinical Lipidology, Vienna, Austria Dec 2014 Notes: Poster Presentation.